S0931
Phase 3 Completed
1,545 enrolled 15 charts
3-AP in Treating Patients With Previously Untreated Locally Recurrent or Metastatic Renal Cell Carcinoma
Phase 2 Completed
19 enrolled
OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid Tumors
Phase 1 Completed
40 enrolled
Radiation Therapy in Treating Patients With Newly Diagnosed Brain Metastases From Kidney Cancer, Melanoma, or Sarcoma
Phase 2 Completed
Paclitaxel and Carboplatin in Treating Patients With Locally Advanced or Metastatic Renal Cell Cancer
Phase 2 Completed
22 enrolled
Sunitinib Malate With or Without Gemcitabine Hydrochloride in Treating Patients With Advanced Kidney Cancer That Cannot Be Removed By Surgery
Phase 2 Completed
87 enrolled 11 charts
Second-line Pazopanib Renal Cell Carcinoma (RCC) Study. CTRIAL-IE (ICORG) 10-01, V5
Phase 2 Completed
43 enrolled
Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors
Phase 2 Completed
291 enrolled 18 charts
Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors
Phase 1 Completed
16 enrolled
SWOG-9023, DNA Analysis of Tumor Tissue From Patients With Metastatic Kidney Cancer
Completed
34 enrolled
Kidney-Sparing Surgery Compared With Kidney Removal in Treating Patients With Kidney Cancer
Phase 3 Completed
S0312, Gemcitabine and Capecitabine in Treating Patients With Advanced Renal Cell (Kidney) Cancer
Phase 2 Completed
43 enrolled
Interleukin-2, Interferon Alfa, and Fluorouracil Compared With Observation in Treating Patients Who Have Undergone Surgery for Kidney Cancer
Phase 3 Completed
96 enrolled
NGR-TNF in Treating Patients With Advanced Solid Tumors
Phase 1 Completed
70 enrolled
Interferon Alfa With or Without Isotretinoin in Treating Patients With Metastatic Kidney Cancer
Phase 3 Completed
320 enrolled